Background
In 1962, Headington and French first described trichilemmoma as a benign neoplasm with differentiation toward pilosebaceous follicular epithelium,[1] or outer root sheath. Their significance resides in the association with Cowden disease (multiple hamartoma syndrome) and the need to differentiate trichilemmomas from other more aggressive cutaneous tumors, such as trichilemmal carcinoma.
Clinically, trichilemmomas present as well-defined, smooth, asymptomatic papules or verrucoid growths. They may appear as a solitary or multiple lesions, and are usually found on the head and face (see the image below). These papules often mimic a basal cell carcinoma or a verruca.
A patient with trichilemmoma papules on the face. Trichilemmomas are often reported in association with several other nevi, most commonly nevus sebaceous of Jadassohn.[2] Several articles have reported trichilemmomas also appearing alongside trichoblastoma, sebaceous adenoma, and syringocystadenoma papilliferum.[3, 4]
When multiple trichilemmomas are present, Cowden disease should be suspected, especially if associated with oral fibromas, goiter, gastrointestinal polyposis, thyroid disease, or a family history of breast cancer.
Pathophysiology
The underlying cause of trichilemmomas is unknown, although because of its histologic similarity to a wart, some researchers have investigated a viral etiology.[5, 6]
Johnson et al[7] performed histologic and ultrastructural analyses of 10 hyperkeratotic lesions on the extremities and 2 keratotic lesions on the face in a patient with Cowden disease. They were unable to find evidence of a viral infection in the tissues examined. Leonardi et al[8] performed a study on 25 trichilemmomas, revealing no evidence of human papillomavirus DNA in the lesions. Most trichilemmomas, therefore, appear to represent a benign tumor with differentiation towards the follicular outer root sheath (trichilemma).[6]
Stierman et al[9] were unable to detect human papillomavirus (HPV)–1, HPV-2, or mixed genital-type HPV infection in trichilemmomas using in situ hybridization. It was suggested that the association between HPV infection and the hair follicle is both one of the permanent sources of HPV DNA and the site of origin for trichilemmomas.[10] The development of trichilemmomas may be independent factors associated with increasing age, rather than HPV being an oncogenic stimulus for trichilemmomas.
Conversely, Rohwedder et al used the polymerase chain reaction (PCR) technique to show 11 cases of HPV-positive trichilemmoma. So far, HPV types 6b, 15, 17, 23, 27, and 28 have been identified in both solitary trichilemmoma lesions and in patients with Cowden syndrome.[10, 11]
Cowden syndrome is a rare autosomal dominant condition characterized by the formation of multiple types of hamartomas and neoplastic growths, which may be found throughout different body systems. This syndrome is thought to be due to the PTEN mutation, a germline mutation in exon 8 of the phosphatase and tensin homolog deleted on chromosome 10.[12] It is a point mutation of C to T at codon 1003 (CGA → TGA, arginine → stop codon). This defect demonstrates incomplete genetic penetrance with variable expressivity. Loss of heterozygosity may lead to tumor formation.[13]
The syndrome is allelic to other PTEN -related syndromes such as Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma) and Bannayan-Riley-Ruvalcaba syndrome, which is characterized by genital lentigines and hamartomatous growths. Families or patients with overlapping features have been described.[14, 15]
Epidemiology
Frequency
United States
Trichilemmomas are relatively common benign neoplasms of the follicular epithelium. Their true incidence is hard to determine and is probably underestimated. Approximately 40 cases per 100,000 consecutive skin biopsies may be found every year in any given dermatopathologic laboratory. Unlike isolated trichilemmomas, multiple trichilemmomas associated with Cowden disease are very rare.
International
The international frequency is unknown.
Mortality/Morbidity
Trichilemmomas are benign follicular epithelial neoplasms. They are associated with minimal morbidity and no mortality. These tumors usually need to be differentiated clinically from a verruca or a basal cell carcinoma. The only morbidity associated with these tumors occurs if they are treated as a basal cell carcinoma before histologic confirmation is obtained.
Race
Trichilemmomas may occur in any race. They are most common in white females, but they have also been reported in Japanese and black patients.
Sex
The male-to-female ratio of trichilemmomas is 1:1; however, Cowden disease has a female predominance, with a male-to-female ratio of 1:3.
Age
Trichilemmomas predominantly occur in patients aged 20-80 years. However, onset may occur as early as age 4 years, with a median age of onset at 30 years.[13]
Desmoplastic trichilemmomas (a histologic subtype of trichilemmoma) predominantly occur in white men over a wide age range, and the highest frequency is in the fifth decade.
Headington JT, French AJ. Primary neoplasms of the hair follicle. Histogenesis and classification. Arch Dermatol. Oct 1962;86:430-41. [Medline].
Baykal C, Buyukbabani N, Yazganoglu KD, Saglik E. [Tumors associated with nevus sebaceous]. J Dtsch Dermatol Ges. Jan 2006;4(1):28-31. [Medline].
Manonukul J, Omeapinyan P, Vongjirad A. Mucoepidermoid (adenosquamous) carcinoma, trichoblastoma, trichilemmoma, sebaceous adenoma, tumor of follicular infundibulum and syringocystadenoma papilliferum arising within 2 persistent lesions of nevus sebaceous: report of a case. Am J Dermatopathol. Oct 2009;31(7):658-63. [Medline].
Wang Y, Bu WB, Chen H, Zhang ML, Zeng XS, Zhao L. Basal cell carcinoma, syringocystadenoma papilliferum, trichilemmoma, and sebaceoma arising within a nevus sebaceus associated with pigmented nevi. Dermatol Surg. Dec 2011;37(12):1806-10. [Medline].
Ackerman AB. Trichilemmoma. Arch Dermatol. Feb 1978;114(2):286. [Medline].
Stierman S, Chen S, Nuovo G, Thomas J. Detection of human papillomavirus infection in trichilemmomas and verrucae using in situ hybridization. J Cutan Pathol. Jan 2010;37(1):75-80. [Medline].
Johnson BL, Kramer EM, Lavker RM. The keratotic tumors of Cowden's disease: an electronmicroscopic study. J Cutan Pathol. Oct 1987;14(5):291-8. [Medline].
Leonardi CL, Zhu WY, Kinsey WH, Penneys NS. Trichilemmomas are not associated with human papillomavirus DNA. J Cutan Pathol. Jun 1991;18(3):193-7. [Medline].
Stierman S, Chen S, Nuovo G, Thomas J. Detection of human papillomavirus infection in trichilemmomas and verrucae using in situ hybridization. J Cutan Pathol. Jan 2010;37(1):75-80. [Medline].
Schaller J, Rohwedder A, Burgdorf WH, Itin PH, Lautenschlager S. Identification of human papillomavirus DNA in cutaneous lesions of Cowden syndrome. Dermatology. 2003;207(2):134-40. [Medline].
Rohwedder A, Keminer O, Hendricks C, Schaller J. Detection of HPV DNA in trichilemmomas by polymerase chain reaction. J Med Virol. Feb 1997;51(2):119-25. [Medline].
Harada N, Sugimura T, Yoshimura R, et al. Novel germline mutation of the PTEN gene in a Japanese family with Cowden disease. J Gastroenterol. 2003;38(1):87-91. [Medline].
Umemura K, Takagi S, Ishigaki Y, Iwabuchi M, Kuroki S, Kinouchi Y. Gastrointestinal polyposis with esophageal polyposis is useful for early diagnosis of Cowden's disease. World J Gastroenterol. Oct 7 2008;14(37):5755-9. [Medline].
Pezzolesi MG, Li Y, Zhou XP, Pilarski R, Shen L, Eng C. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Am J Hum Genet. Nov 2006;79(5):923-34. [Medline].
Sarquis MS, Agrawal S, Shen L, Pilarski R, Zhou XP, Eng C. Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet. Jul 2006;79(1):23-30. [Medline].
Salem OS, Steck WD. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol. May 1983;8(5):686-96. [Medline].
Boulton JE, Sullivan TJ, Whitehead KJ. The eyelid is a site of occurrence of desmoplastic trichilemmoma. Eye. Apr 2001;15(Pt 2):257. [Medline].
Keskinbora KH, Buyukbabani N, Terzi N. Desmoplastic trichilemmoma: a rare tumor of the eyelid. Eur J Ophthalmol. Nov-Dec 2004;14(6):562-4. [Medline].
Roson E, Gomez Centeno P, Sanchez-Aguilar D, Peteiro C, Toribio J. Desmoplastic trichilemmoma arising within a nevus sebaceus. Am J Dermatopathol. Oct 1998;20(5):495-7. [Medline].
Kanoh M, Amoh Y, Sato Y, Katsuoka K. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors. Eur J Dermatol. Sep-Oct 2008;18(5):518-23. [Medline].
Kurokawa I, Senba Y, Nishimura K, Habe K, Hakamada A, Isoda K. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum. In Vivo. Sep-Oct 2006;20(5):583-5. [Medline].
Tardío JC. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol. Jan 2009;36(1):89-102. [Medline].
Hunt SJ, Kilzer B, Santa Cruz DJ. Desmoplastic trichilemmoma: histologic variant resembling invasive carcinoma. J Cutan Pathol. Feb 1990;17(1):45-52. [Medline].
Illueca C, Monteagudo C, Revert A, Llombart-Bosch A. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma. J Cutan Pathol. Sep 1998;25(8):435-9. [Medline].
Schweiger E, Spann CT, Weinberg JM, Ross B. A case of desmoplastic trichilemmoma of the lip treated with Mohs surgery. Dermatol Surg. Jul 2004;30(7):1062-4. [Medline].
Allen BS, Fitch MH, Smith JG Jr. Multiple hamartoma syndrome. A report of a new case with associated carcinoma of the uterine cervix and angioid streaks of the eyes. J Am Acad Dermatol. Apr 1980;2(4):303-8. [Medline].
Aram H, Zidenbaum M. Multiple hamartoma syndrome (Cowden's disease). J Am Acad Dermatol. Nov 1983;9(5):774-6. [Medline].
Brownstein MH, Shapiro L. Trichilemmoma. Analysis of 40 new cases. Arch Dermatol. Jun 1973;107(6):866-9. [Medline].
Chan P, White SW, Pierson DL, Rodman OG. Trichilemmoma. J Dermatol Surg Oncol. Jan 1979;5(1):58-9. [Medline].
Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev. Dec 2010;36(8):577-83. [Medline].
Hoang MP, Levenson BM. Cystic panfolliculoma. Arch Pathol Lab Med. Mar 2006;130(3):389-92. [Medline].
Masmoudi A, Chermi ZM, Marrekchi S, Raida BS, Boudaya S, Mseddi M, et al. Cowden syndrome. J Dermatol Case Rep. Mar 26 2011;5(1):8-13. [Medline]. [Full Text].
Massi D, Franchi A. Desmoplastic trichilemmoma: a case report with immunohistochemical characterization of the extracellular matrix components. Acta Derm Venereol. Sep 1997;77(5):347-9. [Medline].
Mehregan AH. Tumor of follicular infundibulum. Dermatologica. 1971;142(3):177-83. [Medline].
Poblet E, Jimenez-Acosta F, Rocamora A. QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumors. J Cutan Pathol. Jun 1994;21(3):224-8. [Medline].
Robinson S, Cohen AR. Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature. Neurosurg Focus. 2006;20(1):E6. [Medline].
Starink TM, Meijer CJ, Brownstein MH. The cutaneous pathology of Cowden's disease: new findings. J Cutan Pathol. Apr 1985;12(2):83-93. [Medline].
Tellechea O, Reis JP, Baptista AP. Desmoplastic trichilemmoma. Am J Dermatopathol. Apr 1992;14(2):107-4. [Medline].
Thyresson HN, Doyle JA. Cowden's disease (multiple hamartoma syndrome). Mayo Clin Proc. Mar 1981;56(3):179-84. [Medline].
Ung T, Tan JH, Mudhar H. Three patients with desmoplastic tricholemmoma with an incidental histological surprise impacting on management. Br J Ophthalmol. Feb 24 2011;[Medline].
Weary PE, Gorlin RJ, Gentry WC Jr, Comer JE, Greer KE. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. Nov 1972;106(5):682-90. [Medline].

